Novum Peptides

Research use only

Before you enter

Please confirm the following before browsing Novum Peptides.

Adults onlyYou must be 18 years or older to enter.

Laboratory research onlyOur products are not for human or veterinary use.

We’ll remember your confirmation on this browser where storage is available.

Novum Peptides · For laboratory research only

Container-specific stability evidence

Check whether a stability result covers the actual container system, including its closure, presentation and material-contact history.

A stability statement about material stored in a glass vial contains a container condition. Removing that condition changes the claim. The useful question is whether the tested presentation matches the one being assessed, not whether both packages look broadly similar.

Identify the whole tested presentation

Start with the report’s actual description rather than the catalogue photograph. Record the named container material, closure, fill presentation and any additional treatment or component explicitly identified.

Do not complete missing fields from convention. If a paper says only “glass vial”, its description does not identify every feature of the container system. Those omissions limit how confidently another system can be matched.

Original container-evidence comparison
FeatureTested materialProposed material
ContainerNamed glass typeGlass type not documented
ClosureSpecified componentDifferent component code
Material stateDefined solutionDried material

This hypothetical comparison contains three unresolved differences. It does not prove incompatibility. It shows why a direct claim that the published duration covers the proposed material would need more evidence.

Keep a published result inside its container boundary

Andre and colleagues developed a chromatographic method for a two-peptide telomerase-vaccine formulation, including separation of an isoaspartate degradation product. They reported physicochemical stability over two months in borosilicate glass vials at −20°C.Andre and colleagues — Stability-indicating HPLC study of a peptide-based telomerase vaccine (opens in a new tab)

The result names both a particular formulation and a particular presentation. It is not evidence for arbitrary peptide mixtures or for the same material transferred to an unspecified container.Andre and colleagues — Stability-indicating HPLC study of a peptide-based telomerase vaccine (opens in a new tab)

The abstract is enough to identify this boundary, but it is not a complete package specification. A reader considering a material-specific comparison would need the underlying container and study details.

Distinguish matching evidence from a justified bridge

The closest evidence tests the relevant material in the relevant container under the relevant conditions. When one of these differs, the assessment needs an explanation of why the difference does or does not affect the conclusion.

That explanation might use a direct comparison or other material-specific evidence. Simply calling two containers “equivalent” without identifying the basis leaves the central question unanswered.

A change of container after a study has begun also divides the exposure history. The earlier observations describe the original presentation; the later observations include the new one. Preserve the transfer event when interpreting the timeline.

Likewise, evidence about an unopened presentation should not silently be applied to a repeatedly accessed one. The assessment must say which history its conclusion covers, rather than allowing a package name to hide the difference.

Write the applicability conclusion precisely

A useful conclusion separates three possibilities: the tested presentation matches, an identified difference has a documented justification, or applicability remains unresolved. These are more informative than an unsupported binary claim that the container is suitable or unsuitable.

If information is missing, request the specific field or comparison needed. For example, asking whether the reported stability data cover the supplied closure is more actionable than asking whether all glass vials are acceptable.

Keep this conclusion alongside the study reference and the material record. It makes later packaging changes reviewable and prevents a carefully limited stability result becoming an unrestricted rule through repeated reuse.

Sources and further detail

  1. Andre and colleagues — Stability-indicating HPLC study of a peptide-based telomerase vaccine (opens in a new tab)

    Complete original 2025 abstract checked against the publisher record. Borosilicate-vial evidence is used only within its formulation and physicochemical scope.

Sources checked 20 September 2026. Numerical examples are illustrative unless identified as published observations. This article has not undergone independent scientific peer review.